Supporting information

S1 WinBUGS code for adjusting trial results for total bias in meta-analysis
#Bayesian meta-analysis of case study meta-analysis A dataset (Ohlsson and Lacy 2004) , incorporating an informative prior for total bias in each trial at high or unclear risk of bias for sequence generation, allocation concealment and/or blinding. 
s2[i]<-1/(nC[i]*pC[i])+1/(nC[i]*(1-pC[i]))+ 1/(nT[i]*pT[i])+1/(nT[i]*(1-pT[i])) # Approximate within-trial variance w[i]<-1/(s2[i]+tau2) pcw[i] <-(w[i]/sum(w[])
)*100 #Percentage weight of trial in meta-analysis } d ~ dnorm(0,1.0E-5) #Prior for combined intervention effect (log odds ratio) p.tau2<-1/tau2 #Prior for between-trial variance in intervention effect tau2<-tau*tau tau~dunif(0,2) } #Data from 10 trials included in case study meta-analysis A and parameters for trial-specific bias distributions derived from method 3. The trials are ordered as in Figure 1 : 1=Sandberg 2000 , 2=Clapp 1989 , 3=Bussel 1990 , 4=Fanaroff 1994 , 5=Haque 1986 , 6=Weisman 1994a , 7=Chirico 1987 , 8=Conway 1990 , 9=Ratrisawadi 1991 , 10=Tanzer 1997 . #s, study; rC/nC, binary outcome data for control arm; rT/nT, binary outcome data for treatment arm; mu, mean of bias distribution; sigma, standard deviation of bias distribution; X, indicator of a high or unclear risk of bias judgement for at least one of sequence generation, allocation concealment and blinding. 
S2.1 Statistical analysis of the ROBES data
We modelled the estimated intervention effect θim (log odds ratio) in trial i of meta-analysis m as: We allowed for interaction terms between pair-wise combinations of design characteristics.
Interaction terms ijm  (j=4, 5, 6) were assumed to have the same two-level structure as the main effects ijm  (j=1, 2, 3), with distinct variance components. The average bias in trials with more than one high or unclear risk of bias judgement (on the log odds ratio scale) is estimated as the sum of the coefficients representing the effects of individual characteristics and the coefficients representing the interaction terms involving these design characteristics. For example, for a trial at high or unclear risk of bias for sequence generation and allocation concealment and low risk of bias for blinding, the bias in intervention effect relative to a trial at low risk of bias for all characteristics is modelled as
Within the full Bayesian model, we derived an empirical predictive distribution for total bias βnew expected in a new trial with each possible bias profile. For example, a predictive distribution for bias in a trial at high or unclear risk of bias for sequence generation and allocation concealment and low risk of bias for blinding is given by: The derived predictive distributions for bias may serve as empirically-based prior distributions for total bias βi in each trial i in a new binary outcome meta-analysis, within the model for bias adjustment described in the section, "Adjusting for bias".
S2.2 Descriptions of the meta-analyses and trials on which the distributions are based
64 meta-analyses (866 trials) from the ROBES database that assessed subjectively measured outcomes.
All meta-analyses include at least 5 trials and are informative for bias due to inadequate or unclear sequence generation, allocation concealment and blinding.
Distribution of outcome types
Proportion of trials at unclear risk of bias 
S2.3 Empirical distributions for trial-specific biases
For each combination of risk of bias judgements (bias profile), we report a predictive normal distribution for the bias expected in a new trial with that same bias profile relative to a trial at low risk of bias. These distributions were derived from analysis of the 64 binary outcome meta-analyses (866 trials) included in the ROBES database. .10) g).
Risk of bias Bias distribution
Interventions Experimental I:
Received 250 mg/kg of IVIG (Biotest Pharma, West Germany) within 4 hours of birth.
Experimental II:
Received 500 mg/kg of IVIG within 4 hours of birth.
Control:
Received no intervention. Outcome Sepsis (presence of clinical findings of sepsis plus positive blood cultures).
Notes
Experimental group I and II were combined, and entered as one experimental group in the meta-analysis.
Risk of bias assessment and summary of methods used (as described in paper)
Adequate sequence generation? 'Unclear' risk of bias "The infants matched for gestational age, sex, weight and history of prolonged rupture of fetal membrane were randomly allocated into 3 groups of 34 each."
Groups were comparable at baseline.
Allocation concealment? 'Unclear' risk of bias
No details provided.
Blinding? 'High' risk of bias
No placebo was used.
"The drug was not given to group III (controlled group)." Incomplete outcome data addressed?
Infants (number not stated) who expired within 24 hours of life or required blood exchange transfusion were excluded from the study. In spite of these exclusions the number of patients in each group is identical (N=34).
Denominator for analysis was the same as the number randomised per group. Note that the axis is on the log ratio of odds ratios (log ROR) scale, to assist our analyses. We will round the ROR to the nearest 0.02 on the log ROR scale.
S4.2 Elicitation strategy (ii): assessor marks opinion on empirical bias distribution
Assessment Fanaroff 1994
L Sequence generation Evidence from a set of other trials at low risk of bias for sequence generation and allocation concealment and high/unclear risk of bias for blinding suggests that the bias might lie in the distribution represented by the Figure below.
L
Allocation concealment
H/U Blinding
Given this information, where in this distribution do you expect the bias in this particular trial to lie?
Mark the expected ROR value by an X and the inter-quartile range (IQR) by two lines | on the x-axis below. Choose inter-quartile range limits such that you believe the true ROR is equally likely to lie inside rather than outside the range. Provide numerical values if you wish, which may fall outside the range of the x-axis. See below for an example.
Note that the x-axis is on the log ratio of odds ratios (log ROR) scale, to assist our analyses. We will round the ROR to the nearest 0.02 on the log ROR scale.
S4.3 Elicitation strategy (iii): assessor chooses area of empirical bias distribution
Assessment Weisman 1994a
H/U Sequence generation Evidence from a set of other trials at high/unclear risk of bias for sequence generation and allocation concealment and low risk of bias for blinding suggests that the bias might lie in the distribution represented by the Figure Meta-analysis A: opinions on the extent of bias, elicited from four out of twelve assessors, using three different methods. Plots (i) and (ii) display elicited inter-quartile ranges for bias, plot (iii) shows selected areas of empirically-derived bias distributions. H/U/L denote high/unclear/low risk of bias.
NB: The four assessors are not the same for each trial.
